1. Home
  2. SGHT vs TWN Comparison

SGHT vs TWN Comparison

Compare SGHT & TWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • TWN
  • Stock Information
  • Founded
  • SGHT 2011
  • TWN 1986
  • Country
  • SGHT United States
  • TWN Hong Kong
  • Employees
  • SGHT N/A
  • TWN N/A
  • Industry
  • SGHT Medical Specialities
  • TWN Trusts Except Educational Religious and Charitable
  • Sector
  • SGHT Health Care
  • TWN Finance
  • Exchange
  • SGHT Nasdaq
  • TWN Nasdaq
  • Market Cap
  • SGHT 304.4M
  • TWN 306.6M
  • IPO Year
  • SGHT 2021
  • TWN N/A
  • Fundamental
  • Price
  • SGHT $3.54
  • TWN $45.79
  • Analyst Decision
  • SGHT Buy
  • TWN
  • Analyst Count
  • SGHT 7
  • TWN 0
  • Target Price
  • SGHT $6.27
  • TWN N/A
  • AVG Volume (30 Days)
  • SGHT 234.0K
  • TWN 20.1K
  • Earning Date
  • SGHT 11-07-2024
  • TWN 01-01-0001
  • Dividend Yield
  • SGHT N/A
  • TWN 1.10%
  • EPS Growth
  • SGHT N/A
  • TWN N/A
  • EPS
  • SGHT N/A
  • TWN N/A
  • Revenue
  • SGHT $79,543,000.00
  • TWN N/A
  • Revenue This Year
  • SGHT $2.18
  • TWN N/A
  • Revenue Next Year
  • SGHT $8.14
  • TWN N/A
  • P/E Ratio
  • SGHT N/A
  • TWN N/A
  • Revenue Growth
  • SGHT N/A
  • TWN N/A
  • 52 Week Low
  • SGHT $3.16
  • TWN $25.22
  • 52 Week High
  • SGHT $8.45
  • TWN $41.51
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 36.40
  • TWN 53.99
  • Support Level
  • SGHT $3.52
  • TWN $44.67
  • Resistance Level
  • SGHT $3.73
  • TWN $47.24
  • Average True Range (ATR)
  • SGHT 0.20
  • TWN 1.21
  • MACD
  • SGHT 0.01
  • TWN 0.13
  • Stochastic Oscillator
  • SGHT 24.54
  • TWN 50.63

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About TWN Taiwan Fund Inc. (The)

Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.

Share on Social Networks: